Camber Capital Management LP Collegium Pharmaceutical, Inc Transaction History

Camber Capital Management LP

  • $3.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$31.23 - $40.91 $6.16 Million - $8.06 Million
-197,100 Reduced 18.77%
852,900 $33.1 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $16.6 Million - $20.3 Million
-950,000 Reduced 47.5%
1,050,000 $19.6 Million
Q1 2020

May 15, 2020
BUY
$13.89 - $25.45 $27.8 Million - $50.9 Million
2,000,000 New
2,000,000 $32.7 Million

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email